Diabetes Care, Vol 21, Issue 4 494-500, Copyright © 1998 by American Diabetes Association

ARTICLES

Fish oil and glycemic control in diabetes. A meta-analysis

CE Friedberg, MJ Janssen, RJ Heine and DE Grobbee
Department of Internal Medicine, Ziekenhuis der Vrije Universiteit, Amsterdam, The Netherlands. c.friedberg.buro@vu.med.nl

OBJECTIVE: Hypertriglyceridemia is associated with cardiovascular disease in diabetes. Fibrates effectively lower, but do not always normalize, serum triglyceride levels. Fish oil supplements may then be added to lower serum triglyceride levels. Doubt remains whether the net effect of fish oil intake on glycemic control is beneficial in diabetes. We therefore performed a meta-analysis from published clinical trials. RESEARCH DESIGN AND METHODS: Data sources were Medline (Cologne, Germany), Excerpta Medica, Current Contents, review articles, and published reference lists. Publications of 26 trials were selected, and all trials included more than five diabetes (IDDM and NIDDM) patients and addressed the effects of fish oil (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) on serum lipids and glucose tolerance. We (C.E.F., M.J.F.M.J.) extracted data independently based on predetermined criteria. Studies were classified according to design. RESULTS: All studies combined showed a decrease in mean triglyceride concentrations in association with fish oil: -0.60 mmol/l (95% CI, -0.84 to -0.33, P < 0.01) and a slight but significant increase in serum LDL cholesterol: 0.18 mmol/l (95% CI, 0.04-0.32, P = 0.01), with both findings most prominent in NIDDM. No significant changes in HbA1c percentages occurred in diabetic subjects treated with fish oil. Fasting blood glucose levels were increased with borderline significance in NIDDM subjects (0.43 mmol/l [95% CI, 0.00-0.87], P = 0.06) and were significantly lower in IDDM subjects (-1.86 mmol/l [95% CI, -3.1 to -0.61], P < 0.05). Significant dose-response effects of EPA (g/day) on HbA1c and triglycerides and of DHA (g/day) on fasting blood glucose levels, HbA1c, and triglycerides were demonstrated only in NIDDM subjects. CONCLUSIONS: The use of fish oil has no adverse affects on HbA1c in diabetic subjects and lowers triglyceride levels effectively by almost 30%. However, this may be accompanied by a slight increase in LDL cholesterol concentration. Fish oil may be useful in treating dyslipidemia in diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Kabir, G. Skurnik, N. Naour, V. Pechtner, E. Meugnier, S. Rome, A. Quignard-Boulange, H. Vidal, G. Slama, K. Clement, et al. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1670 - 1679. [Abstract] [Full Text] [PDF]

				K. Gura, R. Strijbosch, S. Arnold, C. McPherson, and M. Puder The Role of an Intravenous Fat Emulsion Composed of Fish Oil in a Parenteral Nutrition-Dependent Patient With Hypertriglyceridemia Nutr Clin Pract, December 1, 2007; 22(6): 664 - 672. [Abstract] [Full Text] [PDF]

				R. De Caterina, R. Madonna, A. Bertolotto, and E. B. Schmidt n-3 Fatty Acids in the Treatment of Diabetic Patients: Biological rationale and clinical data Diabetes Care, April 1, 2007; 30(4): 1012 - 1026. [Full Text] [PDF]

				G. PARKER Dr. Parker Replies Am J Psychiatry, November 1, 2006; 163(11): 2018 - 2019. [Full Text] [PDF]

				L. K Nies, A. A Cymbala, S. L Kasten, D. G Lamprecht, and K. L Olson Complementary and Alternative Therapies for the Management of Dyslipidemia Ann. Pharmacother., November 1, 2006; 40(11): 1984 - 1992. [Abstract] [Full Text] [PDF]

				E. J Baldwin Fad diets in diabetes The British Journal of Diabetes & Vascular Disease, September 1, 2004; 4(5): 333 - 337. [Abstract] [PDF]

				D. E Kelley Sugars and starch in the nutritional management of diabetes mellitus Am. J. Clinical Nutrition, October 1, 2003; 78(4): 858S - 864. [Abstract] [Full Text] [PDF]

				M. Evans, A. Roberts, and A. Rees Pharmacological management of hyperlipidaemia The British Journal of Diabetes & Vascular Disease, May 1, 2003; 3(3): 204 - 210. [Abstract] [PDF]

				F. B. Hu, E. Cho, K. M. Rexrode, C. M. Albert, and J. E. Manson Fish and Long-Chain {omega}-3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women Circulation, April 15, 2003; 107(14): 1852 - 1857. [Abstract] [Full Text] [PDF]

				B. Heude, P. Ducimetiere, and C. Berr Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study Am. J. Clinical Nutrition, April 1, 2003; 77(4): 803 - 808. [Abstract] [Full Text] [PDF]

				G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes Diabetes Care, April 1, 2003; 26(4): 1277 - 1294. [Abstract] [Full Text] [PDF]

				P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): e20 - 30. [Full Text] [PDF]

				M. J. Franz So Many Nutrition Recommendations--Contradictory or Compatible? Diabetes Spectr, January 1, 2003; 16(1): 56 - 63. [Full Text] [PDF]

				P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Circulation, November 19, 2002; 106(21): 2747 - 2757. [Full Text] [PDF]

				R. J Woodman, T. A Mori, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1007 - 1015. [Abstract] [Full Text] [PDF]

				E. Dewailly, C. Blanchet, S. Gingras, S. Lemieux, and B. J. Holub Cardiovascular disease risk factors and n-3 fatty acid status in the adult population of James Bay Cree Am. J. Clinical Nutrition, July 1, 2002; 76(1): 85 - 92. [Abstract] [Full Text] [PDF]

				P. G. Fegan, K. M. Macleod, J. E. Tooke, and A. C. Shore n-3 NEFA: vascular implications Eur. Heart J., February 1, 2002; 23(3): 185 - 187. [Full Text] [PDF]

				M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Diabetes Care, January 1, 2002; 25(1): 148 - 198. [Full Text] [PDF]

				E. Dewailly, C. Blanchet, S. Gingras, S. Lemieux, L. Sauve, J. Bergeron, and B. J. Holub Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers Am. J. Clinical Nutrition, November 1, 2001; 74(5): 603 - 611. [Abstract] [Full Text] [PDF]

				C. Lavigne, F. Tremblay, G. Asselin, H. Jacques, and A. Marette Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E62 - E71. [Abstract] [Full Text] [PDF]

				A. V. Möllsten, G. G. Dahlquist, E.-L. Stattin, and S. Rudberg Higher Intakes of Fish Protein Are Related to a Lower Risk of Microalbuminuria in Young Swedish Type 1 Diabetic Patients Diabetes Care, May 1, 2001; 24(5): 805 - 810. [Abstract] [Full Text]

				P N Durrington, D Bhatnagar, M I Mackness, J Morgan, K Julier, M A Khan, and M France An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia Heart, May 1, 2001; 85(5): 544 - 548. [Abstract] [Full Text]

				T. A Mori, D. Q Bao, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects Am. J. Clinical Nutrition, November 1, 1999; 70(5): 817 - 825. [Abstract] [Full Text] [PDF]